Of the 47 patients with a medically treated microprolactinoma (Table 1), 39 (83.0%) were female, 20 (52.6%) had elevated prolactin levels, 13 (27.7%) had hypopituitarism, and 3 (6.4%) had adrenal insufficiency. This evidence concerns the gene PRL and Microprolactinoma.